A September 20 inquiry from Carolina Vilchez inspired our October Quick Question. Here are the stem and responses from 35 participants:

From “Kaarin,” We are wondering what other labs are using for a positive (deficient) control for factor XIII assay by the clot-lysis methodology. Deficient plasma? Hello, Kaarin, thanks for your question, which will attract some responses soon. A quick check of major plasma control distributors shows that only Hyphen BioMed, distributed in North America by Aniara, […]

A reprise of a post from a few years ago: At the Mayo Medical Laboratories Coagulation Testing Quality Conference in Minneapolis, Dr. Dorothy Adcock Funk of Esoterix reported on the 2008 revision of Clinical and Laboratory Standards Institute (CLSI) Standard H21-A5, Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays. One interesting […]

This post duplicates a 2009 FF post. My colleague and friend Dan Southern, Professor Emeritus, Western Carolina University, alerted me to a Wall Street Journal article describing how protein pump inhibitors such as Nexium, taken for gastroesophageal reflux disease (GERD), inhibit the absorption of clopidogrel (Plavix). Many cardiologists prescribe Nexium to control the heartburn some […]

This is a prior-year post that has resurfaced as we have switched over to our new provider and format.

At the 2022 Northeast Laboratory Conference, October 18 and 19, I [Geo] presented "Antithrombotic Therapy, Whatever Happened to Warfarin?"

Venous thromboembolism is a condition in which a clot forms in the deep veins of the leg, groin, or arm [deep vein thrombosis, DVT ].